We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The company will be the first to integrate whole genome sequencing (WGS) into Epic's Aura platform, further advancing access ...

The study will screen babies for more than 200 genetic conditions to enable earlier diagnosis.

In a groundbreaking development, hundreds of newborns have started being tested for over 200 rare genetic conditions as part ...

We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against other ...

has announced the development of a whole-genome sequencing test, named xH, aimed at enhancing personalized treatment for hematological cancer patients. According to InvestingPro data, the company ...

CHICAGO - Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence applications for precision medicine with a market capitalization of $5.9 billion and impressive revenue growth of 32% ...

A team of British scientists has found that a blood test to detect circulating tumour DNA (ctDNA) may help predict lung ...